Primary Site >> Pancreatic Cancer

Gene >> NF1

Journal: Cancer. 2008 Oct 1;113(7 Suppl):1807-43.
Title: Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.
Author: Jensen, Robert T|Berna, Marc J|Bingham, David B|Norton, Jeffrey A
PMID: 18798544
Journal: Drug Discov Ther. 2011 Dec;5(6):266-78.
Title: Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.
Author: Maruta, H
PMID: 22466437
Journal: BMJ Case Rep. 2012 Jun 5;2012. pii: bcr.02.2012.5895.
Title: Gastric GIST with synchronous neuroendocrine tumour of the pancreas in a patient without neurofibromatosis type 1.
Author: Tavares, Amelia Brandao|Viveiros, Fernando Arruda|Cidade, Cassilda Neves|Maciel, Jorge
PMID: 22675144
Journal: World J Surg Oncol. 2012 Jul 23;10:153.
Title: A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1.
Author: Nishi, Takeshi|Kawabata, Yasunari|Hari, Youko|Imaoka, Hiroshi|Ishikawa, Noriyoshi|Yano, Seiji|Maruyama, Riruke|Tajima, Yoshitsugu
PMID: 22824559
Journal: Oncogene. 2014 Sep 18;33(38):4664-74.
Title: microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions.
Author: Ouyang, H|Gore, J|Deitz, S|Korc, M
PMID: 24096486
Journal: JOP. 2014 Nov 28;15(6):600-3.
Title: Mixed periampullary adenocarcinoma and somatostatinoma with small bowel gastrointestinal stromal tumour in neurofibromatosis type 1.
Author: Tewari, Nilanjana|Rollins, Katie|Gandhi, Nirav|Kaye, Phillip|Lobo, Dileep N
PMID: 25435578
Journal: Nihon Hinyokika Gakkai Zasshi. 2015 Jul;106(3):178-84.
Title: [PRIMARY MEDIASTINAL GERM CELL TUMOR ARISING IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1].
Author: Kashima, Soki|Saito, Mitsuru|Tsuchiya, Norihiko|Saito, Hajime|Nanjo, Hiroshi|Numakura, Kazuyuki|Tsuruta, Hiroshi|Akihama, Susumu|Inoue, Takamitsu|Narita, Shintaro|Minamiya, Yoshihiro|Satoh, Shigeru|Habuchi, Tomonori
PMID: 26419075
Journal: J Med Genet. 2016 Nov;53(11):721-727.
Title: An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.
Author: Baker, Maria J|Goldstein, Alisa M|Gordon, Patricia L|Harbaugh, Kimberly S|Mackley, Heath B|Glantz, Michael J|Drabick, Joseph J
PMID: 26794401
Journal: Br J Dermatol. 2016 Oct;175(4):785-9.
Title: CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
Author: Sargen, M R|Merrill, S L|Chu, E Y|Nathanson, K L
PMID: 26876133